Simple HPLC-UV Method for Pharmacokinetic Studies of Imatinib in the Presence of Common Antimalaria Agents

References

• Buchdunger, E.; O’Reilly, T.; Wood, J. Pharmacology of Imatinib (ST1571). Eur. J. Cancer 2002, 38, S28–S36.
   PubMedGoogle Scholar
• Beran, M.; Cao, X.; Estrov, Z.; et al. Selective Inhibition of Cell Proliferation and BCR-ABL Phosphorylation in Acute Lymphoblastic Leukemia Cells Expressing Mr 190,000 BCR-ABL Protein by a Tyrosine Kinase Inhibitor (CGP-57148). Clin. Cancer Res. 1998, 4, 1661–1672.
   PubMed Web of Science ®Google Scholar
• Druker, B. J.; Talpaz, M.; Resta, D. J.; et al. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia. N. Eng. J. Med. 2001, 344, 1031–1037.
   PubMed Web of Science ®Google Scholar
• Durosinmi, M. A.; Faluyi, J. O.; Oyekunle, A. A.; et al. The Use of Imatinib Mesylate in Nigerians with Chronic Myeloid Leukemia, Cell. Ther. Transplant. 2008, 1, e 000027.01c.
   Google Scholar
• Peng, B.; Lloyd, P.; Schran, H. Clinical Pharmacokinetics of Imatinib. Clin. Pharmacokinet. 2005, 44, 879–894.
   PubMed Web of Science ®Google Scholar
• Schreyer, E.; Pursche, S.; Kohne, C. H.; et al. Liquid Chromatographic Method for Detection and Quantitation of STI-571 and Its Main Metabolite N-desmethyl-STI in Plasma, Urine, Cerebrospinal Fluid, Culture Medium and Cell Preparations. J. Chromatogr. B. 2004, 799, 23–36.
   PubMed Web of Science ®Google Scholar
• Vivekanand, V. V.; Sreenivas, R. D.; Vaidyanathan, G.; et al. A Validated LC Method for Imatinib Mesylate. J. Pharm. Biomed. Anal. 2003, 33, 879–889.
   PubMed Web of Science ®Google Scholar
• Velpandian, T.; Mathur, R.; Agarwal, N. K.; et al. Development and Validation of a Simple Liquid Chromatographic Method with Ultraviolet Detection for the Determination of Imatinib in Biological Samples. J. Chromatogr. B 2004, 804, 431–434.
   PubMed Web of Science ®Google Scholar
• Oostendorp, R. L.; Beijnen, J. H.; Schellens, J. H.; et al. Determination of Imatinib Mesylate and Its Main Metabolite (CGP74588) in Human Plasma and Murine Specimens by Ion-pairing Reversed-phase High-performance Liquid Chromatography. Biomed. Chromatogr. 2007, 21, 747–754.
   PubMed Web of Science ®Google Scholar
• Miura, M.; Takahashi, N.; Sawada, K. Quantitative Determination of Imatinib in Human Plasma with High-performance Liquid Chromatography and Ultraviolet Detection. J. Chromatogr. Sci. 2011, 49, 412–415.
   PubMed Web of Science ®Google Scholar
• Parise, R. A.; Ramanathan, R. K.; Hayes, M. J.; et al. Liquid Chromatographic Mass Spectrometric Assay for Quantitation of Imatinib and Its Main Metabolite (CGP 74588) in Plasma. J. Chromatogr. B 2003, 791, 39–43.
   PubMed Web of Science ®Google Scholar
• Guetens, G.; De Boeck, G.; Highley, M.; et al. Quantification of the Anticancer Agent STI-571 in Erythrocytes and Plasma by Measurement of Sediment Technology and Liquid Chromatography-tandem Mass Spectrometry. J. Chromatogr. A 2003, 1020, 27–34.
   PubMed Web of Science ®Google Scholar
• Bakhtiar, R.; Khemani, L.; Hayes, M.; et al. Quantification of the Anti-leukemia Drug STI571 (Gleevec) and Its Metabolite (CGP 74588) in Monkey Plasma Using a Semi-automated Solid Phase Extraction Procedure and Liquid Chromatography-tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2002, 28, 1183–1194.
   PubMed Web of Science ®Google Scholar
• Bakhtiar, R.; Lohne, J.; Ramos, L.; et al. High Throughput Quantification of the Anti-leukemia Drug STI571 (Gleevec) and Its Main Metabolite (CGP 74588) in Human Plasma Using Liquid Chromatography Tandem Mass Spectrometry. J. Chromatogr. B 2002, 768, 325–340.
   PubMed Web of Science ®Google Scholar
• Titier, K.; Picard, S.; Ducint, D.; et al. Quantification of Imatinib in Human Plasma by High-performance Liquid Chromatography–Tandem Mass Spectrometry. Ther. Drug Monit. 2005, 27, 634–640.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry: Bio-analytical Method Validation. FDA, Centre for Drug Evaluation and Research, Rockville, MD, USA, 2001, 4–15.
   Google Scholar